TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
Alto Crescimento
A receita da empresa tem crescido de forma consistente nos últimos 3 anos, com média de 150.59% ano a ano.
Avaliação Justa
O PE mais recente da empresa é 14.31, em uma faixa percentil média de 3 anos.
Venda Institucional
As participações institucionais mais recentes são de 42.29M ações, uma redução de 3.95% em relação ao trimestre anterior.
Mantido por John Hussman
O Super Investidor John Hussman possui 44.62K ações desta empresa.
Baixa Atividade de Mercado
A empresa tem menor interesse dos investidores, com uma taxa de giro de 20 dias de -0.18.